Healthcare & Life Sciences
Forbius
United States
acquiredacquired
acquired
Stage
About
Forbius was a US-based biotechnology company developing oncology therapeutics and was acquired by Bristol-Myers Squibb in 2020.
Explore Forbius's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.